URV's Author/s: | Benaiges Moragrega, Ester / Ceperuelo Mallafré, Maria Victoria / Domínguez Porfirio, Brenno / Fernandez Veledo, Sonia / Keiran Fernandez, Noelia Elisabeth / Martínez Salamero, Luis / Megía Colet, Ana / Vendrell Ortega, Juan José |
Author, as appears in the article.: | Ceperuelo-Mallafre V; Llaurado G; Keiran N; Benaiges E; Astiarraga B; Martinez L; Pellitero S; Gonzalez-Clemente JM; Rodriguez A; Fernandez-Real JM; Lecube A; Megia A; Vilarrasa N; Vendrell J; Fernandez-Veledo S |
Author's mail: | brenno.dominguez@urv.cat sonia.fernandez@urv.cat victoria.ceperuelo@urv.cat luis.martinez@urv.cat juanjose.vendrell@urv.cat ana.megia@urv.cat ester.benaiges@estudiants.urv.cat ester.benaiges@estudiants.urv.cat |
Author identifier: | 0000-0003-2216-8974 0000-0003-2906-3788 0000-0002-4460-9761 0000-0003-3344-9501 0000-0002-6994-6115 0000-0002-5101-9452 |
Journal publication year: | 2019 |
Publication Type: | Journal Publications |
ISSN: | 01495992 |
APA: | Ceperuelo-Mallafre V; Llaurado G; Keiran N; Benaiges E; Astiarraga B; Martinez L; Pellitero S; Gonzalez-Clemente JM; Rodriguez A; Fernandez-Real JM; L (2019). Preoperative circulating succinate levels as a biomarker for diabetes remission after bariatric surgery. Diabetes Care, 42(10), 1956-1965. DOI: 10.2337/dc19-0114 |
Papper original source: | Diabetes Care. 42 (10): 1956-1965 |
Abstract: | © 2019 by the American Diabetes Association. OBJECTIVE To determine the potential use of baseline circulating succinate to predict type 2 diabetes remission after bariatric surgery. RESEARCH DESIGN AND METHODS Forty-five obese patients with diabetes were randomly assigned to Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), or laparoscopic greater curvature plication. Anthropometric parameters were evaluated, and a complete biochemical analysis including circulating serum succinate concentrations was performed at baseline and 1 year after surgery. The results were externally validated in a second cohort including 88 obese patients with diabetes assigned to RYGB or SG based on clinical criteria. RESULTS Succinate baseline concentrations were an independent predictor of diabetes remission after bariatric surgery. Patients achieving remission after 1 year hadlower levels of baseline succinate (47.8 [37.6-64.6] mmol/L vs. 64.1 [52.5-82.9] μmol/L; P = 0.018). Moreover, succinate concentrations were significantly decreased 1 year after surgery (58.9 [46.4-82.4] μmol/L vs. 46.0 [35.8-65.3] mmol/L, P = 0.005). In multivariate analysis, the best logistic regression model showed that baseline succinate (odds ratio [OR] 11.3, P = 0.031) and the type of surgery (OR 26.4, P = 0.010) were independently associated with remission. The C-statistic for this model was 0.899 (95% CI 0.809-0.989) in the derivation cohort, which significantly improved the prediction of remission compared with current available scores, and 0.729 (95% CI 0.612-0.846) in the validation cohort. Interestingly, patients had a different response to the type of surgery according to baseline succinate, with significant differences in remission rates. CONCLUSIONS Circulating succinate is reduced after bariatric surgery. Baseline succinate levels have predictive value for diabetes remission independently of previously described presurgical factors and improve upon the current available scores to predict remission. |
Article's DOI: | 10.2337/dc19-0114 |
Link to the original source: | https://care.diabetesjournals.org/content/42/10/1956 |
Papper version: | info:eu-repo/semantics/acceptedVersion |
licence for use: | https://creativecommons.org/licenses/by/3.0/es/ |
Department: | Medicina i Cirurgia Ciències Mèdiques Bàsiques |
Licence document URL: | https://repositori.urv.cat/ca/proteccio-de-dades/ |
Thematic Areas: | Saúde coletiva Odontología Nutrição Medicina iii Medicina ii Medicina i Internal medicine Interdisciplinar General medicine Engenharias iv Enfermagem Endocrinology, diabetes and metabolism Endocrinology & metabolism Ciências biológicas ii Ciências biológicas i Biotecnología Antropologia / arqueologia Advanced and specialized nursing |
Keywords: | Validation study Succinic acid Sleeve gastrectomy Roux-en-y gastric bypass Risk factor Remission Randomized controlled trial Prospective study Preoperative period Predictive value Prediction Obesity Non insulin dependent diabetes mellitus Middle aged Male Laparoscopic greater curvature plication Human Follow up Female Controlled study Cohort analysis Clinical article Biological marker Biochemical analysis Bariatric surgery Article Anthropometric parameters Adult |
Entity: | Universitat Rovira i Virgili |
Record's date: | 2024-05-23 |
Description: | © 2019 by the American Diabetes Association. OBJECTIVE To determine the potential use of baseline circulating succinate to predict type 2 diabetes remission after bariatric surgery. RESEARCH DESIGN AND METHODS Forty-five obese patients with diabetes were randomly assigned to Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), or laparoscopic greater curvature plication. Anthropometric parameters were evaluated, and a complete biochemical analysis including circulating serum succinate concentrations was performed at baseline and 1 year after surgery. The results were externally validated in a second cohort including 88 obese patients with diabetes assigned to RYGB or SG based on clinical criteria. RESULTS Succinate baseline concentrations were an independent predictor of diabetes remission after bariatric surgery. Patients achieving remission after 1 year hadlower levels of baseline succinate (47.8 [37.6-64.6] mmol/L vs. 64.1 [52.5-82.9] μmol/L; P = 0.018). Moreover, succinate concentrations were significantly decreased 1 year after surgery (58.9 [46.4-82.4] μmol/L vs. 46.0 [35.8-65.3] mmol/L, P = 0.005). In multivariate analysis, the best logistic regression model showed that baseline succinate (odds ratio [OR] 11.3, P = 0.031) and the type of surgery (OR 26.4, P = 0.010) were independently associated with remission. The C-statistic for this model was 0.899 (95% CI 0.809-0.989) in the derivation cohort, which significantly improved the prediction of remission compared with current available scores, and 0.729 (95% CI 0.612-0.846) in the validation cohort. Interestingly, patients had a different response to the type of surgery according to baseline succinate, with significant differences in remission rates. CONCLUSIONS Circulating succinate is reduced after bariatri |
Type: | Journal Publications |
Contributor: | Universitat Rovira i Virgili |
Títol: | Preoperative circulating succinate levels as a biomarker for diabetes remission after bariatric surgery |
Subject: | Advanced and Specialized Nursing,Endocrinology & Metabolism,Endocrinology, Diabetes and Metabolism,Internal Medicine Validation study Succinic acid Sleeve gastrectomy Roux-en-y gastric bypass Risk factor Remission Randomized controlled trial Prospective study Preoperative period Predictive value Prediction Obesity Non insulin dependent diabetes mellitus Middle aged Male Laparoscopic greater curvature plication Human Follow up Female Controlled study Cohort analysis Clinical article Biological marker Biochemical analysis Bariatric surgery Article Anthropometric parameters Adult Saúde coletiva Odontología Nutrição Medicina iii Medicina ii Medicina i Internal medicine Interdisciplinar General medicine Engenharias iv Enfermagem Endocrinology, diabetes and metabolism Endocrinology & metabolism Ciências biológicas ii Ciências biológicas i Biotecnología Antropologia / arqueologia Advanced and specialized nursing |
Date: | 2019 |
Creator: | Ceperuelo-Mallafre V Llaurado G Keiran N Benaiges E Astiarraga B Martinez L Pellitero S Gonzalez-Clemente JM Rodriguez A Fernandez-Real JM Lecube A Megia A Vilarrasa N Vendrell J Fernandez-Veledo S |
Rights: | info:eu-repo/semantics/openAccess |
Search your record at: |
File | Description | Format | |
---|---|---|---|
DocumentPrincipal | DocumentPrincipal | application/pdf |
© 2011 Universitat Rovira i Virgili